DVAI34 Stock Overview
Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
DaVita Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$893.42 |
| 52 Week High | US$1,047.54 |
| 52 Week Low | US$604.00 |
| Beta | 0.93 |
| 1 Month Change | -11.80% |
| 3 Month Change | -3.84% |
| 1 Year Change | 45.13% |
| 3 Year Change | 42.30% |
| 5 Year Change | 206.62% |
| Change since IPO | 345.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| DVAI34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -11.0% | 4.7% | 2.6% |
| 1Y | 45.1% | -12.6% | -6.1% |
Return vs Industry: DVAI34 exceeded the BR Healthcare industry which returned -12.1% over the past year.
Return vs Market: DVAI34 exceeded the BR Market which returned -6% over the past year.
Price Volatility
| DVAI34 volatility | |
|---|---|
| DVAI34 Average Weekly Movement | 6.1% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in BR Market | 9.8% |
| 10% least volatile stocks in BR Market | 3.2% |
Stable Share Price: DVAI34 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine DVAI34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 76,000 | Javier Rodriguez | www.davita.com |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
DaVita Inc. Fundamentals Summary
| DVAI34 fundamental statistics | |
|---|---|
| Market cap | R$71.78b |
| Earnings (TTM) | R$5.34b |
| Revenue (TTM) | R$73.05b |
13.4x
P/E Ratio1.0x
P/S RatioIs DVAI34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DVAI34 income statement (TTM) | |
|---|---|
| Revenue | US$12.82b |
| Cost of Revenue | US$8.60b |
| Gross Profit | US$4.22b |
| Other Expenses | US$3.28b |
| Earnings | US$936.34m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 11.70 |
| Gross Margin | 32.91% |
| Net Profit Margin | 7.31% |
| Debt/Equity Ratio | 441.4% |
How did DVAI34 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 09:41 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DaVita Inc. is covered by 35 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephan Gasteyger | Atlantic Equities LLP |
| Brian Williams | Avondale Partners |
| Matthew Gillmor | Baird |